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Mr. Corey Cudzilo has thoughtfully addressed an issue of exceptional contemporary importance,
the smallpox vaccination program. This program was begun in response to the terrorist acts at
the World Trade Center as part of the government's actions to protect the nation from terrorism,
including bioterrorism. Although a selection of biological agents have been identified as
potential terrorism threats, anthrax and smallpox have received the most attention. Anthrax is a
proven threat; however, if smallpox poses at threat is an arguable issue.
Mr. Cudzilo has analyzed available information and has concluded that the proposed smallpox
vaccination program may pose a greater threat to the citizens of this nation than a potential
bioterrorismaction using the smallpox virus. His argument is sound, and his recommendations
are viable and supportable. There is no available evidence that smallpox is possessed by terrorist
groups, but the potential harm of the vaccine is established. The nation can be protected with a
dramatically modified version of the vaccination program that does not require mass
immunization of the general population.
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Abstract:
In an age of heightened concern over bioterrorism and biowarfare, smallpox stands out as
a threat if for nothing else than the severity of the disease it causes. In response to this
threat, the Bush Administration has announced a Smallpox Vaccination Program, but
questions and concerns abound from health care workers, military personnel, and the
general public. The average American has had no reason to know the basics of the
disease and the risks and benefits of the vaccine against it until now. However, most
Americans aren't educated on the clucial information, and thus cannot make an informed
decision or form an objective opinion. This paper seeks to educate the reader on
smallpox and its vaccination while discussing the Smallpox Vaccination Program-to
determine whether it is necessary, efficient, or warranted.
Fifteen, ten, or even five years ago the words "bioterrorism" and "biowarfare"
were not part of this country's everyday vernacular. We, however, live in a new world
and a different time. Yes, biological agents have been used in wars and against people
for centuries, but the threat of bioterrorism or biological warfare has never been so
public, so sensationalized in the media, or such a part of our government's agenda. As
cliche as it is, September 11,2001 really did change our nation and made it almost fearful
of what else could be done. Immediately after the attacks the Office of Homeland
Security was created. Our country experienced terror alerts for the first time, five levels
of increasing risk for terrorist attacks, compiled from unknown sources and information.
President Bush designated an "Axis of Evil": Iran, Iraq, and North Korea. These
countries are believed or are known to have nuclear, chemical, and biological weapons
and the capacity and the will to use them. The FBI went on a nationwide manhunt for
members or associates of Al Qaeda, the terrorist group responsible for the attacks on the
World Trade Center. Almost weekly the news is dominated by the arrest of an individual
involved with terrorism, domestically or abroad. Iraq, a nation designated by the
President to possess Weapons of Mass Destruction (WMD) and ruled by a heartless
dictator whose regime raped its country and its citizens is no longer a nation as it once

2
was, due to an invasion of Coalition Forces led by United States and British armed
forces.
It appears as if the United States either has terrorists running away with their tails
between their legs or irritated like a hive of wasps, depending on one's point of view.
The use of biological agents in terrorism or warfare is still a concern for our nation, both
in the government and the general public. In December of 2002 the President announced
the Smallpox Vaccination Program, a plan to "better protect the American people against
the threat of smallpox attack by hostile groups or governments" (1). At first glance this
statement seems directly in line with the policy of our government to protect the United
States from bioterrorism. Smallpox is a deadly virus that could be used in bioterrorism;
however, a second glance and two minutes of research would tell someone that smallpox
has been officially eradicated from this planet since 1980 (2). So why vaccinate
America? Is there any real threat? What are the risks? What are the benefits? This
paper seeks to determine if nationwide smallpox vaccinations are warranted, necessary,
and/or efficient, and to conduct a risklbenefit analysis of the proposed Smallpox
Vaccination Program. If nothing else, the average American probably does not know
enough information about smallpox and it's vaccination to make an informed decision on
whether or not to be vaccinated. This paper also seeks to inform the average American
on the basics of the smallpox virus and the vaccine against the disease.

History
Smallpox is without question the most devastating disease known to humans. The
smallpox virus has killed, crippled, or disfigured nearly one-tenth of all humankind. In
th

the 20 century alone, more than 300 million people died due to smallpox. It dwarfs
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other illnesses such as the plague (Black death), cholera, and yellow fever in tenns of its
universal impact and destructive results.
The emergence of smallpox can be traced back to early settlements in Africa
around 10,000 Be (6). From there it was spread outward to India and Egypt. Evidence
of facial lesions are present in mummies dating 1570-1085 BC. The first epidemic
occurred in 1350 BC dUling the Egyptian-Hittite war. Egyptian prisoners spread the
disease to the Hittite population, eventually causing the decline of the Hittite civilization.
There were epidemics in ancient Greece (430 BC) and in the Roman Empire. The early
stages of Rome's decline were partially due to a large epidemic that killed between 3.5
and 7 million people. The disease spread west as a result of the Arab expansion, the
Crusades, and the discovery of land across the Atlantic Ocean. Smallpox was
instrumental in the fall of the Incan and Aztec empires, brought to the New World by
Spanish explorers. It decimated the Native American population, brought here by
English colonialists and even used against resisting tribes of Indians (6).
Royalty or wealth was not a bamer to infection. Smallpox killed the Roman
emperor Marcus Aurelius in AD 180; Aztec emperor Ciutlahuac in 1520; Emperor
Ferdinand IV of Austria in 1654; Emperor Gokomyo of Japan in 1654; Queen Mary II of
England in 1694; Tsar Peter II of Russia in1730; and King Louis XV of France in 1774.
In some ancient cultures, infants were not named until they caught the disease and
survived. Smallpox was the cause of one-third of all blindness in 18 th century Europe,
when 400,000 people died from smallpox every year. During the 18 th century, oneseventh of all Russian newborns died from smallpox, and one-tenth of children born in
Sweden (2)(6)
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It was known that if an individual survived a smallpox infection they were
immune to any further infection. With that knowledge, it was the common practice of the
day to infect healthy individuals by intentionally exposing them to persons with mild
cases of the disease, in hopes that the resulting infections would be less severe yet still
provide immunity. Also, various parts of infected persons, from pus to pustules to scabs,
were routinely used to "immunize" healthy individuals. This method was named
"variolation" and comes from the designation of smallpox as variola in 570 AD. That
word comes from the Latin varus, meaning "mark on the skin". Variolation was
practiced in the East for over a hundred years before it was introduced and became an
accepted method in Europe. Lady Montague was an English aristocrat and was
responsible for the acceptance of variolation in England. Variolation soon traveled
across the ocean to America and was used extensively by the mid_18 th century. Fatality
rates of variolated persons were ten times lower than those of naturally occurring
smallpox. However, two to three percent of variolated people died; many more
developed other illness like tuberculosis from infected donors (6). Nonetheless, in 1722
the fatality rate from smallpox was 1:14 in naturally occurring cases and 1:91 in
variolated children (7).
th

It was also known during the 18 century that persons previously infected with
cowpox experienced no reaction to variolation, and seemed to be immune to smallpox.
Cowpox infected few humans, usually milkmaids or farmers who were in close contact
with cows. A few citizens toyed with experiments involving cowpox and variolation, but
gave up before any conclusive evidence was found. By 1788 an English scientist named
Edward Jenner had begun to compile information, study cases, and design experiments to
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test if prior infection of cowpox provided immunity from smallpox. In 1796 he began his
experiments by using fluid drained from a cowpox pustule on an infected milkmaid to
inoculate an eight-year-old boy. Subsequent attempts at variolation produced no visible
results, suggesting immunity. At the end of 1796, Jenner brought his findings, now
totaling 13 cases, to the Royal Society. His theory was rejected and Jenner was sent
away. Jenner decided to personally finance the publication of his findings and soon
appeared with this as the title of his paper: " An inquiry into the causes and effects of the

variale vaccinae, a disease discovered in some of the western counties of England,
particularly Gloucestershire, and known by the name of cow pox". Jenner had used the
word vaccinae, from the Latin vaca, meaning "cow" to describe the phenomenon that
conferred immunity to 13 persons previously infected with cowpox. After initial
skepticism, the practice of vaccination became extremely popular. By 1800, an estimated
100,000 people had been vaccinated against smallpox. Vaccination spread from England
to the rest of Europe and to the United States (6).
Jenner went on to receive numerous accolades, preside over an institute named
after him, and gain worldwide popularity over his discovery. He technically did not
discover the practice of vaccination, but brought a scientific approach to the procedure
and determination to spread knowledge of its success.

Smallpox
The smallpox virus (Poxvirus variolae) is one of the largest and most complex
viruses known. It is a DNA virus, Baltimore classification class I, and a member of the
Poxviridae family, Chordopoxvirinae subfamily, and Orthopoxvirus genus. It is
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characteristically a brick-shaped structure with a diameter of about 200-400 nanometers.
The Poxviruses were the first viruses to be "seen"-the aggregation of viral particles
(elementary bodies) in an infected host are large enough to be seen by a powerful light
microscope when stained. Pox viruses are extremely complex antigens and they induce
both specific and cross-reactive antibodies. This antigenic property is what allows for a
relatively harmless vaccination for smallpox using another Orthopoxvirus, Vaccinia
virus, which will be discussed in more detail later (3).
The smallpox genome consists of about 250 genes and replicates in the cytoplasm
of the host cell upon entry. After entry, smallpox follows the lytic cycle of viruses,
meaning it 1) uncoats from its envelope 2)

replicates its genome into concatemers 3)

transcribes its genome 4) expresses its genome using viral enzymes 5) assembles the viral
particles in the cell's cytoskeleton 6) matures in the golgi complex of the cell and 7) is
released from the cell along with other mature virions, causing cell lysis and death (3).
There are two clinical forms of smallpox. Variola major is the strain most
associated with the smallpox disease. The minor strain causes similar symptomology but
has a mortality rate of less than 1%. There are four types of variola major smallpox:
ordinary (-90% of cases); modified (occurs in individuals vaccinated previously); flat;
and hemorrhagic. Both the flat and hemorrhagic types are rare and severe, usually
resulting in death (4)(www .cdc.gov/smallpox).
There are many identified clinical features of a smallpox infection. InitiaIJy there
is a 12-14 day incubation period when the individual looks and feels healthy and is
unable to transmit the virus to others. The incubation period is followed by the sudden
onset of flu-like symptoms (called the prodrome) characterized by fever, a temperature
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usually exceeding 101 degrees, headache, malaise, back pain, and occasionally vomiting
and general abdominal pain. After two to three days the individual's temperature drops
and symptoms are relieved. The characteristic rash begins to appear, initially on the face
and extremities and later progressing to the trunk. Lesions develop in the mucous
membranes of the nose and mouth that soon ulcerate and release large amounts of virus
into the mouth and throat. At this time the individual is the most contagious. The rash on
the body develops into raised bumps by the third day, and soon the bumps fill with a
thick opaque fluid. The bumps often have a depression in the center, which is a
distinguishing characteristic of smallpox. The bumps become pustules and are firm to the
touch and sharply raised from the skin. Most of the pustules will scab over after about
five days of their appearance. The scabs will fall off, leaving pitted scars in their place.
Death occurs in 30% of individuals infected with variola major, usually resulting from
immune complex mediated shock. Between 65-80% of survivors are marked with the
deep-pitted scars caused when the scabs fall off, usually most notable on the face.
Scabbing and the eventual scarring of the eyes can cause blindness and historically has
been a major cause of blindness (2) (5).
The history of the disease suggests that the human population is universally
susceptible to infection of the smallpox virus. Transmission of the virus is possible
through direct contact with a symptomatic person. Individuals with the characteristic
cough can spread aerosols and air droplets containing the virus. The virus can also be
transmitted through contaminated bedding and clothing, although not as prevalently as
face-to-face contact. It is important to note that infected persons in the incubation period
cannot transmit the virus. Infectivity is the highest during the prodrome stage of the
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disease and the first week of the rash. The infected individual remains contagious until
the last scab falls off. Typically the disease spreads rather slowly, infecting only close
contacts in small vicinity, unless a ventilation system exists in a building such as an
apartment complex. Today it is estimated that an initially infected person, called an
index case, could infect as many as ten other individuals (2)(4) .

Modern Vaccination
The modem version of Jenner's cowpox vaccination contains live vaccinia virus,
another member of the orthopoxvirus family. Vaccinia is closely related to variola virus
but confers immunity to smallpox while not causing smallpox. Most vaccine consists of
pulp scraped from vaccinia-infected animal skins of sheep or cattle (4). The Vaccinia
virus vaccine proved to be more effective and obtainable than Jenner's cowpox-based
vaccine. But despite 20 th century advances in medicine and vaccination specifically, in
the 1950's an average of 50 million people were still infected with smallpox per year.
Gradual increase of emphasis for vaccination reduced the number of infections to 10-15
million per year (2).
The smallpox vaccine is unique because it is not administered by a hypodermic
needle. Instead, the vaccine is given using a bifurcated needle that is dipped into the
vaccine solution. The skin (usually the arm) is then pricked several times with the twopronged needle. Successful vaccination results in a red, itchy bump that develops at the
penetration site within three to four days. The bump progressively swells, becomes a
large blister filled with pus, and then begins to drain. In the second week the blister dries
and a scab forms. The scab falls off a week later, leaving a scar. Special care is taken to
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prevent the spread of the vaccinia virus from the site of vaccination, since the virus can
cause rash, fever, and body aches. Serious side effects are possible in certain groups of
people, which will be discussed later (4).
In 1967 the World Health Organization began an intensified plan to eradicate
smallpox through vaccination. In ten years the WHO's campaign reduced smallpox from
a worldwide threat to human livelihood to the African country of Somalia. There, in the
village of Merka, a cook by the name of Ali Maow Maalin developed the characteristic
rash associated with smallpox. He survived and recovered and became the last naturally
occurring documented case of smallpox in the world; global eradication of smallpox was
confirmed by the World Health Assembly on May 8 th , 1980.
Unfortunately, the book on smallpox has never been altogether closed. The
Center for Disease Control in Atlanta and the Institute for Viral Preparations in Moscow
are the only known locations where smallpox exists. The remaining stocks have been
slated for destruction on several occasions, but a lack of consensus by board members of
the WHO has delayed destruction.

Those in opposition to the destruction of the

remaining virus contend that future study of the virus would be impossible and that
destroying the stocks does not guarantee the absolute eradication of the virus. Those in
favor of destruction argue that any escape of the virus from its two known homes raises a
risk of use in bioterrorism ancl/or biowarfare, which is something that some feel may
have already happened (6).
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New Concerns
This country is currently in an unfamiliar position regarding terrorism on U.S.
soil. The September 11 th attack on the World Trade Center were the apparent
culmination of years of pent-up hatred for Americans and their way of life. Soon after 911, the country was again terrorized by anthrax sent through the postal system. The U.S.
government has taken new steps to protect its citizens and resources. The Center for
Disease Control has listed smallpox as a Class A Bioterrorism Agent, the highest concern
and most dangerous classification. Reasoning for this classification and concern stem
from the discontinuation of smallpox vaccinations over 20 years ago and resulting
susceptibility to the virus (8). It is estimated that 80% of the population has no prior
immunity to infection. There is also concern that despite the documentation that only
two facilities possess the smallpox virus, it is possible that a terrorist group or rogue
nation could have smallpox samples (5). This concern from the scientific community
appeared several years before September 11, 2001. The variola virus meets several
criteria of any potential bioterror weapon:
1. It is highly transmissible by the aerosol route from infected to susceptible
persons.
2. The civilian populations of most countries contain a high proportion of
susceptible persons
3. Smallpox is associated with high morbidity and about 30% fatality
4. Initially, diagnosis of a disease that has not been seen for 25 years would be
difficult
5. A person may transmit the disease before exhibiting characteristic features of
the disease such as the rash and pustules
6. Other than the vaccine, which can still be effective in the first few days of
infection, there is no known and proven treatment for smallpox (5) .

In response to these concerns, which emerged in the late 1990's but were
amplified after the September 11 th terrorist attacks, President Bush announced a plan for
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a Smallpox Vaccination Program in December of 2002. The plan called for the
formation of Smallpox Response Teams, voluntary health care workers vaccinated
against smallpox that would "provide critical services to their fellow Americans in the
event of a smallpox attack" (1). Also included in the plan are certain military and civilian
personnel working or deployed to "high risk" areas. The Bush Administration
acknowledges in the plan that smallpox is not an imminent threat, but believes it is wise
to "strengthen the preparedness for bioterror attacks by expanding the national stockpile
of smallpox vaccine" (1). The Program does not recommend that members of the general
public be vaccinated at this point, but is steadily working to procure sufficient doses of
the vaccine for every citizen of this country.

The Controversy Begins
Immediately following Bush's announcement, vocal sides formed on the issue.
Some welcomed the program as a necessary protective measure against one of the most
serious potential bioterror weapons. The chief of the CDC, Dr. Julie Gerberding, favors
the program--"The President's decision to recommend this vaccine ... was really based on
the fact that we need urgent and efficient action because we live in a dangerous world
these days, where a terrorist attack with smallpox is possible" (9). Asked about the threat
of a smallpox attack, virologist Dr. Don Francis said "It scares me. It's a dangerous
disease, and we have little immunity" (10). Others, however, vehemently opposed the
program as dangerous in itself and not worth the risks. "We're not sure anybody has
smallpox virus," contends Dr. Daniel Blumenthal, a specialist once involved in the
WHO's smallpox eradication program, "and yet now we are reinstituting vaccination"
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(9). Several union groups, including the American Federation of State, County and
Municipal Employees (AFSCME) and healthworkers.org, oppose the plan because of the
risks involved in vaccination (11) (12).
There are health risks involved in receiving the vaccination. It is estimated that
for everyone million people vaccinated, up to fifty would experience life-threatening
complications and one or two would die(13)(9). Also, 1,000 people for every 1 million
people vaccinated would experience serious but not life-threatening reactions (4).
The program got off to a slow start on January 24, 2003 when only four doctors
out of a twenty member "Genesis Team" from Connecticut turned out to be vaccinated
(l4)(story.news.yahoo.com!news/2003122). Connecticut was the first state to take part in
the program, which began with Smallpox Response Teams from each state and
eventually 500,000 more health care workers. Similar turnouts have been seen in most
other states. As of April 4' 2003, only about 31,000 health care workers and about
350,000 military personnel had received vaccinations (15) (16). The plan contained three
phases: the first phase was to vaccinate the emergency teams, numbering some 400,000
health care workers, and approximately half a million military personnel. The second
phase seeks to inoculate 10 million "first responders" . The third phase, with an
unknown timetable, is to vaccinate the general public.
The program has experienced several setbacks in the last few months. Most
visible is the lack of participation by the majority of the country's health care workers.
Also, as of 4/04/03, about seventy people vaccinated experienced moderate to severe
reactions to the vaccine, while three people have died from heart complications believed
to have been aggravated by the vaccine (15). More recently, the United States led a
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coalition invasion of Iraq, which has taken precedence over the program and a shift in the
Bush administration's focus. These factors have led to an increased vocalization from
those opposed to the program, or at least the program as it now exists. Opponents note
the increased risk of complications from persons with heart disease, immune disorders, or
a history of eczema. There have also been calls for the development of an improved
vaccine, one that does not have the potential for serious or life-threatening reactions.
"We would like to see a less-toxic vaccine," says Dr. Roger Pomerantz, director of the
Center for Human Virology at Thomas Jefferson University (17). The Noravax
Company claims that its version of the vaccine, a IGlled instead of live virus, is safer,
although its effectiveness is unproven. Recently the Department of Health and Human
Services signed a second contract with the British finn Acambis to produce 209 million
doses by the end of 2004. The Acambis contract totals more than $850 million (17).
The Bush Administration has reacted to some of the concerns. It recently
implemented a compensation plan for individuals injured from a vaccination. The CDC
has also issued a ten page Smallpox Response Plan and Guidelines, updated to deal with
a possible attack and smallpox emergency. Still, some states have suspended their
vaccination programs until health risks and potential reactions can be further investigated.

My Two Cents Worth

Much of the opposition appears to stem from a lack of education on smallpox , the
vaccine, or the threat of attack . The general public has been infonned repeatedly on the
possibility of a rogue nation or terrorist group possessing smallpox, but no specifics are
ever given. "My concern is we had a politicization of the scientific process," says Dr.
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Linda Rosenstock, dean of the UCLA School of Public Health, " ... one might defend
making national security actions and war plans on information that can't be shared with
the public. I just can't see any justification malGng public health policy in that same
mindset of secrecy" (9). It appears that policy is being made without sufficient education
of health care workers, much less the general public. There is a fear, which is somewhat
justified, of the unknown concerning this virus and this vaccine. Americans should no
sooner blindly believe their government about a given issue than should the media. Both
are capable of spinning the facts and emphasizing what they choose. Public opinion,
which so far has been less than receptive to the program, is almost certain to shift if the
Bush Administration would provide some specific details on the possible possession of
smallpox by a terrorist group or rogue nation. Combine a mysterious virus that has not
appeared in 25 years with a vaccine that could seriously harm and probably cause some
pain, and you get 30,000 out of

400,000 people following a plan. If Bush and his

Administration want this program to succeed, America needs first to be educated and
provided with real information. A terror alert of orange is not sufficient.
None of this is to say that Bush's plan is a bad plan. Smallpox is certainly a
serious disease and the questions surrounding its availability to terrorist groups are real
enough to warrant some measure of national protection against a smallpox attack.
However, it does not appear that mass, nationwide vaccinations are a necessary or costefficient measure. A more efficient plan would certainly axe phase three of the program,
and very possibly phase two as well.
A simulation of a deliberate smallpox attack created by biostatistics professors at
Emory University's Health Science Center concluded that targeted vaccination of close
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contacts of smallpox-infected individuals would rival that of mass vaccinations. The
scientists based their conclusions on their knowledge of community interactions and
immunity existing from new vaccinations of Smallpox Response Teams, residual
immunity from prior vaccination, and voluntary vaccinations in the general public. In
this model, additional vaccinations would only be administered to those in close contact
with an infected individual, such as household members, school or daycare centers,
neighborhoods, and communities. The simulation also factored in varying levels of
residual immunity, where transmission was likely to highest (households), and the
likelihood of interaction and transmission within a community each day after infection
occurred. They also assumed that smallpox is most likely to be transmitted in close
contact rather than casual or indirect contact on the street or in a subway (18). If such a
simulation is accurate, hundreds or thousands of people could avoid serious side effects
from the vaccine, and hundreds of millions of dollars saved from not vaccinating the
entire nation.
The Program also seems to be getting ahead of itself, launching huge initiatives to
vaccinate before even enough vaccine is produced to vaccinate the entire country.
Information about the disease and vaccine is changing as well. The CDC rewrote part of
its website that stated that the vaccine only protects for three to five years. Studies show
that people vaccinated even fifty years ago still have some protection and a much lower
risk of dying from a smallpox infection than someone that has never been vaccinated
(17). With that information known, does that exclude someone born before 1972, the
year the U.S. ended its smallpox vaccination program, from needing to receive a
vaccination if Phase three is carried out? What about the thousands of Americans that do
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not even know they have a heart condition? What are the chances that terrorists would
attack America with smallpox after everyone has been vaccinated?
With so many variables, questions, and unknowns, the Bush Administration needs
to be first concerned with educating health care workers, military personnel, and the
general public alike about the disease and vaccine. Smallpox Response Teams are a good
idea, and have been shown through simulation to be effective against a smallpox attack.
Hundreds of millions of dollars could be diverted towards research for a safer vaccine,
apprehension of terrorists, or back to the general budget. Yes, smallpox is quite possibly
the worst disease humans have ever seen, but an entire generation has never even seen the
disease or the effects it leaves. Smallpox has been absent for a quarter of a century, and
most Americans educated on the topic do not believe we should all be protected from it.

